Restylane Lyft with Lidocaine for Chin Augmentation

This trial tests the safety of a dermal filler called Restylane Lyft with Lidocaine for enhancing the chin area. Researchers aim to assess the treatment's safety three months after a follow-up treatment. It suits individuals seeking to improve the appearance of a receding chin who have not undergone previous facial surgeries or have allergies to certain substances. Participants will receive an initial chin treatment, with optional touch-ups and retreatments. As an unphased trial, this study allows participants to contribute to understanding the treatment's safety profile.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that Restylane Lyft with Lidocaine is generally well-tolerated. In one study, 87 to 98 percent of participants expressed satisfaction with the results after 12 weeks. Most side effects were mild to moderate, indicating that any negative reactions were not serious and could be managed. The FDA has approved Restylane Lyft with Lidocaine for chin enhancement. However, the safety of this treatment has not been confirmed for pregnant women, breastfeeding women, or individuals under 22 years old. Overall, evidence suggests it is safe for most adults seeking to improve their chin profile.¹²³⁴⁵

Restylane Lyft with Lidocaine is unique for chin augmentation because it combines hyaluronic acid with lidocaine, a local anesthetic, to enhance comfort during the procedure. Most dermal fillers focus solely on volume with hyaluronic acid, but this treatment aims to make the experience less painful and more appealing for patients. Additionally, it offers the option for touch-up treatments, which can help maintain results effectively over time, potentially leading to higher patient satisfaction. Researchers are excited about its potential to provide immediate, natural-looking results with minimal discomfort.

Studies have shown that Restylane Lyft with Lidocaine effectively improves chin shape. In trials, 99.1% of researchers and 94.4% of participants observed a visible improvement in chin appearance three months after treatment. This improvement persisted, with 95.5% of participants still noticing benefits 12 months later. The treatment also resulted in high satisfaction, as 98.3% of participants reported feeling happy or very happy with their results 18 months after their last injection. This evidence clearly supports the effectiveness of Restylane Lyft with Lidocaine for enhancing chin shape and profile.²⁴⁵⁶⁷